Roche says skin cancer drug substantially shrinks (Reuters)
Reuters – A new skin cancer drug from Roche had “remarkable” results in a mid-stage trial, substantially shrinking tumors and lesions in patients with a potentially fatal type of skin cancer, the Swiss drugmaker said on Saturday.
View full post on Yahoo! News: Health News
Leave a Reply